• Something wrong with this record ?

Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma

V. Vašků, J. Máchal, F. Zlámal, A. Vašků

. 2022 ; 13 (12) : . [pub] 20221218

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't

AIM: Cutaneous T-cell lymphoma (CTCL) is a group of T-cell malignancies that develop in the skin. Though studied intensively, the etiology and pathogenesis of CTCL remain elusive. This study evaluated the survival of CTCL patients in the 1st Department of Dermatovenereology of St. Anne's University Hospital Brno. It included analysis of 19 polymorphic gene variants based on their expected involvement in CTCL severity. MATERIAL AND METHODS: 75 patients with CTCL, evaluated and treated at the 1st Department of Dermatovenereology of St. Anne ́s University Hospital Brno, Faculty of Medicine, Masaryk University, were recruited for the study over the last 28 years (44 men and 31 women, average age 58 years, range 20-82 years). All patients were genotyped for 19 chosen gene polymorphisms by the conventional PCR method with restriction analysis. A multivariate Cox regression model was calculated to reveal genetic polymorphisms and other risk factors for survival. RESULTS: The model identified MDR Ex21 2677 (rs2032582) as a significant genetic factor influencing the survival of the patients, with the T-allele playing a protective role. A multivariate stepwise Cox regression model confirmed the following as significant independent risk factors for overall survival: increased age at admission, clinical staging of the tumor, and male sex. CONCLUSION: We showed that the TT genotype at position 2677 of the MDR1 gene exhibited statistically significant longer survival in CTCL patients. As such, the TT genotype of MDR1 confers a significant advantage for the CTCL patients who respond to treatment.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032136
003      
CZ-PrNML
005      
20230131151806.0
007      
ta
008      
230120s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/genes13122401 $2 doi
035    __
$a (PubMed)36553668
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Vašků, Vladimír $u 1st Department of Dermatovenereology, St. Anne's University Hospital, Faculty of Medicine, Masaryk University, 65691 Brno, Czech Republic
245    10
$a Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma / $c V. Vašků, J. Máchal, F. Zlámal, A. Vašků
520    9_
$a AIM: Cutaneous T-cell lymphoma (CTCL) is a group of T-cell malignancies that develop in the skin. Though studied intensively, the etiology and pathogenesis of CTCL remain elusive. This study evaluated the survival of CTCL patients in the 1st Department of Dermatovenereology of St. Anne's University Hospital Brno. It included analysis of 19 polymorphic gene variants based on their expected involvement in CTCL severity. MATERIAL AND METHODS: 75 patients with CTCL, evaluated and treated at the 1st Department of Dermatovenereology of St. Anne ́s University Hospital Brno, Faculty of Medicine, Masaryk University, were recruited for the study over the last 28 years (44 men and 31 women, average age 58 years, range 20-82 years). All patients were genotyped for 19 chosen gene polymorphisms by the conventional PCR method with restriction analysis. A multivariate Cox regression model was calculated to reveal genetic polymorphisms and other risk factors for survival. RESULTS: The model identified MDR Ex21 2677 (rs2032582) as a significant genetic factor influencing the survival of the patients, with the T-allele playing a protective role. A multivariate stepwise Cox regression model confirmed the following as significant independent risk factors for overall survival: increased age at admission, clinical staging of the tumor, and male sex. CONCLUSION: We showed that the TT genotype at position 2677 of the MDR1 gene exhibited statistically significant longer survival in CTCL patients. As such, the TT genotype of MDR1 confers a significant advantage for the CTCL patients who respond to treatment.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mladý dospělý $7 D055815
650    _2
$a dospělí $7 D000328
650    _2
$a lidé středního věku $7 D008875
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    12
$a nádory kůže $x genetika $x patologie $7 D012878
650    12
$a kožní T-buněčný lymfom $x genetika $7 D016410
650    _2
$a polymorfismus genetický $7 D011110
650    _2
$a genotyp $7 D005838
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Máchal, Jan $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic $1 https://orcid.org/0000000282923145
700    1_
$a Zlámal, Filip $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic
700    1_
$a Vašků, Anna $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic $1 https://orcid.org/0000000299565823
773    0_
$w MED00174652 $t Genes $x 2073-4425 $g Roč. 13, č. 12 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36553668 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151802 $b ABA008
999    __
$a ok $b bmc $g 1891109 $s 1183471
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 13 $c 12 $e 20221218 $i 2073-4425 $m Genes $n Genes $x MED00174652
LZP    __
$a Pubmed-20230120

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...